From MedPage Today:

  1. Sulfonylureas May Raise Death Risk. When taken as first-line therapy, sulfonylureas may increase the risk of death in patients with type 2 diabetes.
  2. Parkinson's Makes for Distrust, Risk-Taking. Compared with healthy controls, patients with Parkinson's disease were markedly less trusting of strangers in a psychosocial experiment, even while showing greater willingness to take risks.
  3. Cholesterol Meds May Hold Glycemic ...

    Read more...

From MedPage Today:

  1. AAFP to Look at Allowing NPs, PAs to Join. The American Academy of Family Physicians wants to further study whether nurse practitioners (NPs) and physician assistants (PAs) should -- or would want to -- become non-voting members.
  2. Insulin Pump Fights Arterial Stiffness. Use of an insulin pump was associated with less arterial stiffness than multiple daily injections in patients with type ...

    Read more...

From MedPage Today:

  1. Type 1 Diabetes Not Controlled in Teens. Glucose control remained inadequate in a cohort of teens with type 1 diabetes, and many of these young patients already had microvascular complications.
  2. White House Seeks to Ease Obamacare Fraud Fears. The White House unveiled several steps this week to protect consumers from fraud in the new online health insurance marketplaces, a move that ...

    Read more...

You probably already know that what you do know about your medicine could kill you. You may not know that what you don't know could do so as well. Hold that somber thought -- we'll get back to it. You, and I, and everyone else has seen those direct-to-patient drug ads that Big Pharma runs on primetime television. Invariably, they feature a person skipping through butterflies and wildflowers, demonstrating the ...

Read more...

From MedPage Today:

  1. Botox OK'd for Smoothing Crow's Feet. The botulinum toxin drug Botox Cosmetic can be marketed for temporarily reducing moderate to severe lateral canthal lines -- better known as crow's feet -- in adults.
  2. Lawmakers Can Help Diabetes Guideline Uptake. Healthcare professionals and policymakers can make better use of the law to promote effective interventions for diabetes control and prevention.

  3. Read more...

Minutes from melting in the summer heat, I dumped my stuff at a table and homed in on the hospital café’s soda display for something -cold. The gentleman at the next table glanced my way and said, "Are you in the medical field?" "Yes sir, I’m a medical student." He eyed my drink and asked, "Did you hear that diet soda can increase your risk of diabetes by 70%? Even just a few ...

Read more...

I used to think medicine would get easier over time. It makes sense, right? You see patterns, you learn how treatments work, and you just get to know stuff. Experience should make it easier to diagnose and treat. That’s not been the case for me. In fact, it’s closer to the opposite. In the exam room, as I look up to the patient from my stool, and before I stand at ...

Read more...

From MedPage Today:

  1. Fruit Takes a Bite Out of Diabetes Risk. Eating more fruit, particularly apples, grapes, and blueberries, meant lower type 2 diabetes risk.
  2. Congress Probing VA Bonuses to Doctors. A congressional committee is using a recent report questioning performance bonuses given to Department of Veterans Affairs physicians as reason to examine a range of pay-for-performance issues at the VA.
  3. Financial ...

    Read more...

From MedPage Today:

  1. Indoor Tanning Still Common in Girls, Women. Indoor tanning among adolescent girls and young women rises through the teen years, peaking at about 18 through 21, and then declines with age.
  2. 1 Autistic Child in Family Hikes Risk for More. Younger siblings of children with autism spectrum disorders (ASDs) had a greater risk of being affected with an ASD themselves.

  3. Read more...

From MedPage Today:

  1. Data Promising for Next-Gen Inhaled Insulin. Two late-stage trials in patients with type 1 and type 2 diabetes have shown benefits for the latest incarnation of rapid-acting inhaled insulin (Afrezza) over insulin and oral diabetes drugs.
  2. Byetta May Help in Type 1 Diabetes, Too. The GLP-1 agonist exenatide (Byetta), used in type 2 diabetes, may have metabolic effects on patients with ...

    Read more...